Cancer cell plasticity during tumor progression, metastasis and response to therapy

A Pérez-González, K Bévant, C Blanpain - Nature cancer, 2023 - nature.com
Cell plasticity represents the ability of cells to be reprogrammed and to change their fate and
identity, enabling homeostasis restoration and tissue regeneration following damage. Cell …

Molecular mechanisms of tumor resistance to radiotherapy

Y Wu, Y Song, R Wang, T Wang - Molecular Cancer, 2023 - Springer
Background Cancer is the most prevalent cause of death globally, and radiotherapy is
considered the standard of care for most solid tumors, including lung, breast, esophageal …

First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b/2 trial

M Thibaudin, JD Fumet, B Chibaudel, J Bennouna… - Nature Medicine, 2023 - nature.com
Although patients with microsatellite instable metastatic colorectal cancer (CRC) benefit from
immune checkpoint blockade, chemotherapy with targeted therapies remains the only …

Inflammation: the incubator of the tumor microenvironment

D Denk, FR Greten - Trends in Cancer, 2022 - cell.com
An inflammatory microenvironment, either conferred by an underlying chronic overt or
smoldering inflammatory condition constitutes a prerequisite and fuel to essentially all …

Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade

C Conche, F Finkelmeier, M Pešić, AM Nicolas… - Gut, 2023 - gut.bmj.com
Objective Investigating the effect of ferroptosis in the tumour microenvironment to identify
combinatory therapy for liver cancer treatment. Design Glutathione peroxidase 4 (GPx4) …

IL1R1+ cancer-associated fibroblasts drive tumor development and immunosuppression in colorectal cancer

E Koncina, M Nurmik, VI Pozdeev, C Gilson… - Nature …, 2023 - nature.com
Fibroblasts have a considerable functional and molecular heterogeneity and can play
various roles in the tumor microenvironment. Here we identify a pro-tumorigenic IL1R1+, IL …

Colorectal cancer organoid–stroma biobank allows subtype-specific assessment of individualized therapy responses

HF Farin, MH Mosa, B Ndreshkjana, BM Grebbin… - Cancer discovery, 2023 - AACR
In colorectal cancers, the tumor microenvironment plays a key role in prognosis and therapy
efficacy. Patient-derived tumor organoids (PDTO) show enormous potential for preclinical …

[HTML][HTML] Expansion of T memory stem cells with superior anti-tumor immunity by Urolithin A-induced mitophagy

D Denk, V Petrocelli, C Conche, M Drachsler… - Immunity, 2022 - cell.com
T memory stem cells (T SCM) display increased self-renewal and prolonged survival
capabilities, thus preventing T cell exhaustion and promoting effective anti-tumor T cell …

The advent of immune stimulating CAFs in cancer

M Tsoumakidou - Nature Reviews Cancer, 2023 - nature.com
The theory that cancer-associated fibroblasts (CAFs) are immunosuppressive cells has
prevailed throughout the past decade. However, recent high-throughput, high-resolution …

Cancer-associated fibroblasts in inflammation and antitumor immunity

KB Kennel, M Bozlar, AF De Valk, FR Greten - Clinical Cancer Research, 2023 - AACR
Tumor-associated inflammation (TAI) is a feature of essentially all cancers and can confer
both tumor-promoting and-suppressive functions. Cancer-associated fibroblasts (CAF) …